AHR and Hepatic steatosis: However, the administration of endogenous agonists of AhR such as cinnabarinic acid (CA) down-regulated CD36 and reduced the uptake of free fatty acids in hepatocytes, thus achieving the inhibition of hepatic steatosis and liver injury (Patil et al., 2022).